News about "clinical trial "

Centivax Begins Phase-I Trial of Universal Flu Vaccine

Unlike conventional seasonal influenza vaccines, which must be reformulated annually to attempt to match predicted circulating strains, Centi-Flu 01 is designed to focus both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate, and are shared across strains and distance subtypes.

Clinical Trial | 13/02/2026 | By News Bureau

PharmaResearch Wins FDA Clearance for Phase-I Trial of PRD-101

PRD-101 is a next-generation nano anti-cancer drug candidate formulated using nucleotide fragments produced through PharmaResearch's proprietary DOT (DNA Optimising Technology).

Clinical Trial | 07/02/2026 | By News Bureau

SK Bioscience Begins Study of Sarbecovirus Vaccine

SK bioscience has initiated a global phase I/II clinical trial of GBP511, a universal vaccine candidate targeting the Sarbecovirus family, leveraging its SKYCovione recombinant protein platform and nanoparticle technology as part of the company’s mid- to long-term strategy to advance next-generation vaccines for future pandemic preparedness.

Clinical Trial | 30/01/2026 | By News Bureau

Boehringer Ingelheim's Apecotrep Cuts Proteinuria by 40 percent in Phase II Trial for Rare Kidney Disease FSGS

Phase II data show apecotrep, a first-in-class oral TRPC6 inhibitor, significantly reduced proteinuria in patients with primary FSGS, supporting ongoing Phase III development.

Clinical Trial | 29/01/2026 | By News Bureau

Bridge to Life Secures FDA De Novo Clearance for VitaSmart HOPE System in Liver Transplantation

Bridge to Life has received FDA De Novo clearance for its VitaSmart HOPE System, creating a new regulatory pathway for hypothermic oxygenated perfusion in US liver transplantation.

Clinical Trial | 21/01/2026 | By News Bureau |  166

HistoIndex Partners Houston Research Institute to Expand AI-Driven Diagnostics for MASH Care

HistoIndex has partnered with Houston Research Institute to deploy AI-powered digital pathology and fibrosis assessment tools across HRI centres, enhancing diagnostic precision and clinical decision-making for MASH patients.

Clinical Trial | 21/01/2026 | By News Bureau |  100

Rakuten Medical and LOTTE Biologics Sign Manufacturing Deal for Global Oncology Programme

Rakuten Medical has entered into a manufacturing agreement with LOTTE Biologics under which LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates, supporting Rakuten Medical’s global clinical development programmes and future commercialisation in oncology.

Clinical Trial | 19/01/2026 | By News Bureau

Organon Wins FDA Approval to Extend Duration of Use for NEXPLANON

Organon has received US Food and Drug Administration (FDA) approval for a supplemental New Drug Application extending the duration of use of NEXPLANON, its etonogestrel radiopaque contraceptive implant, to up to five years, expanding the product’s earlier three-year indication and offering longer-lasting contraceptive protection.

Clinical Trial | 17/01/2026 | By News Bureau |  332

Boehringer Ingelheim Begins Phase IIa Trial of BI 765423 in IPF

Boehringer Ingelheim has initiated a Phase IIa clinical trial of BI 765423, a novel IL-11–targeting monoclonal antibody, in patients with Idiopathic Pulmonary Fibrosis (IPF), advancing its efforts to develop new treatment options for progressive fibrotic lung diseases.

Clinical Trial | 15/01/2026 | By News Bureau |  168

HUTCHMED Begins Phase III Trial of Surufatinib-Camrelizumab Combo in Pancreatic Cancer

HUTCHMED has initiated the phase-III stage of its phase-II/III clinical trial in China evaluating a combination regimen of surufatinib, camrelizumab, nab-paclitaxel, and gemcitabine as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma, with the first patient dosed on 30 December, 2025.

Clinical Trial | 05/01/2026 | By News Bureau